Co-mutations of CTNNB1 and PTEN drive aggressive tumor progression in endometrial cancer
Disease Models & Mechanisms · 01.07.2026 · 19 (7)
DOI: 10.1242/dmm.052788 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 18.06.2026. Verfasst von Shamsun Nahar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology and Women's Health, University of Missouri School of Medicine, Columbia, MO 65203, USA. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, beta Catenin, Endometrial Neoplasms, Disease Progression. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Endometrioid endometrial cancer (EEC) is the most prevalent gynecological malignancy. While early-stage EEC typically carries a favorable prognosis, late-stage EEC shows significantly poorer outcomes, with a five-year survival rate of only 17−19%. Co-occurring PTEN and CTNNB1 variants are frequent in EEC and linked to poor prognosis. To investigate their functional impact, we generated uterine-specific Pten knockout mice and dominantly stabilized Ctnnb1 mutant mice (Pgrcre/+Ptenf/fCtnnb1f(ex3)/+; Ptend/dCtnnb1f(ex3)/+). These double-mutant mice exhibited significantly reduced survival compared to single Pten knockout (Pgrcre/+Ptenf/f; Ptend/d) mice. Histopathology revealed aggressive, metastatic endometrioid cancer in Ptend/dCtnnb1f(ex3)/+ mice; these mice developed myometrial invasion by four weeks of age – unlike Ptend/d mice. Transcriptomic analysis identified activation of multiple oncogenic pathways, including WNT/CTNNB1, PI3K/AKT, basal cell carcinoma, sonic hedgehog signaling and epithelial−mesenchymal transition (EMT). Immunohistochemistry confirmed hallmark features of EMT in the uterus of double-mutant mice, including strong downregulation of E-cadherin (CDH1) and upregulation of the EMT regulator SNAIL (Snai1). These findings demonstrate that synergistic mutations of PTEN and CTNNB1 promote early invasion, EMT activation, and metastatic progression, offering mechanistic insight into the aggressive behavior and poor clinical outcomes associated with this subtype of EEC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, Gynecology and Women's Health, University of Missouri School of Medicine, Columbia, MO 65203, USA.
- Department of Pathology and Laboratory Medicine, University of North Carolina, School of Medicine, Chapel Hill, NC 27599, USA.
- Department of Biomedical Laboratory Science, Yonsei University Mirae Campus, Wonju 26493, Republic of Korea.
ORCID-Profile: Shamsun Nahar, Eunhee M Jeong, Keun Cheon Kim, Russell Broaddus, Jung-Yoon Yoo, Jae-Wook Jeong, Kyeong A So, Tae Hoon Kim
Förderung
- NIH HHS
- NCI NIH HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Nahar, S., Jeong, E. M., Kim, K. C., Broaddus, R., Yoo, J. Y., Jeong, J. W., So, K. A., & Kim, T. H. (2026). Co-mutations of CTNNB1 and PTEN drive aggressive tumor progression in endometrial cancer. Disease Models & Mechanisms, 19(7). https://doi.org/10.1242/dmm.052788
Vancouver
Nahar S, Jeong EM, Kim KC, Broaddus R, Yoo JY, Jeong JW, et al. Co-mutations of CTNNB1 and PTEN drive aggressive tumor progression in endometrial cancer. Disease Models & Mechanisms. 2026;19(7). doi:10.1242/dmm.052788
BibTeX
@article{Nahar2026,
author = {Nahar, Shamsun and Jeong, Eunhee M and Kim, Keun Cheon and Broaddus, Russell and Yoo, Jung-Yoon and Jeong, Jae-Wook and So, Kyeong A and Kim, Tae Hoon},
title = {Co-mutations of CTNNB1 and PTEN drive aggressive tumor progression in endometrial cancer},
journal = {Disease Models & Mechanisms},
year = {2026},
volume = {19},
number = {7},
doi = {10.1242/dmm.052788}
}
EUVIMED